DolCas Biotech’s Morikol next-gen bioactive, flavourless, tripeptide collagen with high bioavailability, sachet format. DolCas Biotech, LLC, a leader in clinically researched nutraceutical ingredients, announces the introduction of a new format for…

DolCas Biotech’s Morikol next-gen bioactive, flavourless, tripeptide collagen with high bioavailability, sachet format.

DolCas Biotech, LLC, a leader in clinically researched nutraceutical ingredients, announces the introduction of a new format for its Morikol marine collagen tripeptide ingredient.  This new delivery system will be on display at Vitafoods Europe 2026 in Barcelona,

The new format consists of 1g and 2g single-serving sachets of Morikol’s neutral-in-odour-and-flavour collagen tripeptide that can be opened and ingested directly. Because the ingredient is 100 per cent water-soluble, the melt-in-your-mouth powder can be consumed directly without mixing into liquids and without any aftertaste.

Morikol, already recognised for its superior bioavailability, clinically demonstrated efficacy, and exceptional formulation flexibility, is a bioactive glycine-proline-hydroxyproline (GPH) tripeptide that, unlike most collagen ingredients, provides for efficient absorption, even within a food or beverage matrix. Its unique mechanism ensures Morikol gets rapidly absorbed into circulation and can exert specific biological activity.  

“This new format offers consumers a fast, convenient way to take collagen anywhere, anytime, which can also help support rapid absorption due to the highly bioavailable tripeptide structure,” explains K G Rao, founder and CEO of DolCas Biotech. “Conventional collagen peptides often recommend consumption on an empty stomach for optimal absorption, but when DolCas performed a comprehensive critical review of the ingredient, superior standardisation properties were revealed that made it unique compared to other collagen products.”